Product/Composition:- | Omeprazole tablets |
---|---|
Strength:- | 20 mg, 40 mg |
Form:- | Tablet |
Reference Brands:- | Prilosec(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Omeprazole tablets work by irreversibly inhibiting the gastric H⁺/K⁺ ATPase enzyme in stomach lining cells, reducing acid production. Benefits include relief from acid reflux, gastroesophageal reflux disease (GERD), and ulcers, promoting healing of the esophagus and stomach, and preventing acid-related damage and discomfort.
Omeprazole tablets are approved in both the US and EU, with regulatory oversight from the FDA and EMA. These products are supported by detailed dossiers demonstrating safety, efficacy, and manufacturing quality under GMP standards. In the US, Prilosec is a leading branded formulation, while in the EU, generic and branded versions like Losec are common. Regulatory approval involves rigorous clinical evaluation and documentation. For comprehensive information on licensing, approved dossiers, and regulatory requirements for omeprazole tablets, visit Pharmatradz. Stay updated on the latest regulatory developments and licensing processes for omeprazole in global markets.